Nordic Tech Weekly — 2026-07-17
Swedish preventive healthtech platform Neko Health has landed a blockbuster $700M Series C to fuel US expansion, marking the week's largest Nordic funding round. Meanwhile, Danish biotech startup Visibuilt raised €3.34M seed for mycelium-based construction materials, and Stockholm fintech Float secured €4.5M Series A. The week also saw a major shift in pre-seed funding as Swedish VC fund Norrsken Evolve closed its €62M fund at first close, formalizing expansion into the Netherlands.
Nordic Tech Weekly — 2026-07-17
Top Funding Rounds
Neko Health (Sweden) — $700M Series C
- What they do: Preventive healthtech platform offering AI-powered health screening and personalized wellness insights
- Investors: Led by major institutional investors; round positions Neko for aggressive international expansion
- Why it matters: This is one of the largest Series C rounds for a Nordic health startup, reflecting strong investor appetite for preventive care solutions. The US market entry marks a critical milestone for Nordic medtech's transatlantic expansion.
Visibuilt (Denmark) — €3.34M Seed
- What they do: Develops mycelium-based construction binder as a sustainable alternative to cement and concrete
- Investors: Co-led by EIFO and Unconventional Ventures, with participation from multiple climate tech-focused investors
- Why it matters: Underscores the Nordic region's leadership in climate-conscious deeptech and biotech. Mycelium-based materials address decarbonization in construction—a critical sector for net-zero goals.
Float (Sweden) — €4.5M Series A
- What they do: AI-native finance platform for European startups, automating financial operations and reporting
- Investors: Led by CHAPTERS Group AG; CHAPTERS CEO Jan-Hendrik Mohr joined the board
- Why it matters: Demonstrates continued momentum in Nordic fintech for B2B solutions addressing startup finance friction, a proven pain point in the region's ecosystem.
InfiniNode Technologies (Sweden) — €2M (Investment + Grant)
- What they do: Develops on-chip data movement technology to reduce latency and power consumption in semiconductor systems
- Investors: Combination of venture investment and government grant funding
- Why it matters: Reflects Nordic strength in deep-tech semiconductors and strong public-private partnerships for hardware innovation.
Cornea Sense (Finland) — €1.1M+ Pre-Seed
- What they do: Aalto University spinout developing non-invasive corneal hydration measurement for ophthalmic diagnostics
- Investors: Innovestor Angel and other angel investors
- Why it matters: University-backed deeptech demonstrates Finland's continued strength in health-tech innovation and academic entrepreneurship.
Launches & Product News
- Norrsken Evolve (Sweden): The pre-Seed climate-tech VC fund closed its Fund II at €62 million first close and formally opened a Dutch office. This expansion signals Nordic climate capital moving into continental Europe and underscores Norrsken's role as a leading impact investor in the region.
- Algiecel (Denmark): The Copenhagen-based microalgae company appointed Mette Ingeman Pedersen as CFO and strengthened its female-led leadership team with the appointment of Tove Feld as board chair. This reflects the Nordic ecosystem's focus on diversity in climate and biotech leadership.
Exits & M&A
No major Nordic tech M&A transactions or IPO closings were announced in the past 7 days. However, the broader Nordic M&A landscape remains active: according to market data, the first half of 2026 saw Nasdaq's Nordic exchanges lead Europe's listing landscape, with strong investor confidence in Nordic growth companies and scaleups. The region continues to attract both PE sponsors and strategic acquirers, with mid-market deals (€1M–€200M revenue) showing particular momentum across Denmark, Sweden, Finland, and Norway.
Looking forward, Nordic dealmakers are positioning for increased M&A activity in late 2026, with dual-track processes and founder exits expected to accelerate as economic conditions stabilize.
Nordic Spotlight
The Rise of Nordic Climate & Biotech Capital: Why Sustainability Startups Are Attracting Mega-Rounds
This week's funding announcements underscore a strategic shift in Nordic venture capital: climate-adjacent deeptech and biotech startups are now commanding the region's largest rounds. Neko Health's $700M Series C and Visibuilt's €3.34M seed are not outliers—they reflect a deliberate ecosystem bet on solving existential challenges in health and construction.
The Nordic region has carved a unique position as the global leader in climate-tech venture capital per capita. Norrsken Evolve's €62M fund close and expansion into the Netherlands signals that Nordic climate VCs are now exporting their model across Europe. This is significant because it marks a shift from Silicon Valley's traditional venture model (growth at all costs) to a Nordic model (growth + impact).
Visibuilt's mycelium-based binders exemplify this perfectly. Cement production accounts for ~8% of global CO2 emissions; solving this problem with biotechnology is not just a market opportunity—it's a mission-critical investment. The fact that EIFO (an impact fund) co-led the round alongside traditional VCs shows how climate-tech has moved from niche impact investing into mainstream venture strategy.
For founders, this means the Nordic region is now the place to build climate and health-tech companies that solve real problems. Unlike earlier cycles where VCs chased SaaS and fintech, today's Nordic capital flows toward companies addressing decarbonization, circular economy, and preventive health—sectors where regulatory tailwinds and customer demand are aligned.
The risk: if climate tech becomes too crowded in the Nordics, we may see capital rotation back to traditional venture (AI, fintech, e-commerce) by 2027. But for now, the region's commitment to sustainable innovation remains its clearest competitive advantage.
What to Watch Next Week
-
Nasdaq Nordic IPO Pipeline: Keep an eye for any mid-market Nordic companies entering roadshow phase in late July; several founders have indicated plans to go public in Q3 2026 given recent market confidence.
-
Norrsken Fund II Close Timeline: Norrsken Evolve has signaled a full close expected by Q4 2026; watch for portfolio company announcements and deal flow updates from their expanded European presence.
-
Algiecel Funding Round: Following the leadership team strengthening, Algiecel may announce a Series A within the next 4–6 weeks; microalgae-based biotech solutions are attracting significant institutional interest from sustainability-focused LPs.
Nordic Tech Weekly is generated from Arctic Startup, EU-Startups, Sifted, and real-time Nordic venture news feeds.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
